Cancer BiologybioRxiv
Dual G9A and EZH2 inhibition stimulates an anti-tumour immune response in ovarian high-grade serous carcinoma
P. Spiliopoulou, S. Spear, H. Mirza…·I. McNeish
This study shows that dual inhibition of G9A and EZH2 in ovarian cancer enhances anti-tumour immune responses by altering the immune microenvironment and reducing tumour growth.
DOI 10.1158/1535-7163.mct-21-0743